Clinical value of urinary kidney biomarkers for estimation of renal impairment in elderly Chinese with essential hypertension

Journal of Clinical Laboratory Analysis

Volumn 22, Issue 1, 2008, Pages 86-90

  Xu, XunHui ^a   Fang, Yi ^a   Ji, Jun ^a   Jiang, SuHua ^a   Xing, DingGuang ^b   Fei, ShaoHua ^c   Ding, XiaoQiang ^a  

^a FUDAN UNIVERSITY   (China)

^b Hospital of Shanghai   (China)

^c Yangjin Hospital   (China)

Author keywords

Elderly essential hypertension; Specific types of urinary proteins; Urinary enzyme glomerular filtration rate

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; N ACETYL BETA GLUCOSAMINIDASE; RETINOID BINDING PROTEIN; TRANSFERRIN;

ADULT; AGED; AGING; ARTICLE; CHINESE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEIN URINE LEVEL; RENOVASCULAR HYPERTENSION; URINARY EXCRETION;

ACETYLGLUCOSAMINIDASE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; SERUM ALBUMIN; TRANSFERRIN;

EID: 39449092217     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20220     Document Type: Article

References (21)

1. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple risk factor intervention trial. J Am Med Assoc 1997;278:2069-2074.
2. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-18.
3. Mountokalakis TD. The renal consequences of arterial hypertension. Kidney Int 1997;51:1639-1653.
4. Johnson RJ, Schreiner GF. Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int 1997;52:1169-1179.
5. Chelliah R, Sagnella GA, Markandu MD, MacGregor GA. Urinary protein and essential hypertension in black and in white people. Hypertension 2002;39:1064-1070.
6. Ogihara T, Hiwada K, Morimoto S, et al. Guidelines for treatment of hypertension in the elderly. Hypertens Res 2003;26:1-36.
7. Kaplan LA, Pesce AJ, Kazmierczak SC. Renal function in clinical chemistry: theory, analysis and correlation, 4th edition. St. Louis: Mosby Publishing Co.; 2003. p 487.
8. Clozel M, Hess P, Fischli W, et al. Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear disease. Exp Gerontol 1999;34:1007-1015.
9. Kashif W. Proteinuria: how to evaluate an important finding. Cleve Clin J Med 2003;70:535-547.
10. Kirsztajn GM, Nishida SK, Silva MS, Ajzen H, Moura LA, Pereira AB. Urinary retinol-binding protein as a prognostic marker in glomerulopathies. Nephron 2002;90:424-431.
11. Bang LE, Holm J, Svendsen TL. Retinol-binding protein and transferrin in urine. New markers of renal function in essential hypertension and white coat hypertension? Am J Hypertens 1996;9:1024-1028.
12. Zeller A, Haehner T, Battegav E, Martina B. Diagnostic significance of transferrinuria and albumin-specific dipstick testing in primary care patients with elevated office blood pressure. J Hum Hypertens 2005;19:205-209.
13. Alli C, Lombardo M, Zanni D, Agrati AM, Cassani M, Granata S. Albuminuria and transferrinuria in essential hypertension: effects of antihypertensive therapy. Am J Hypertens 1996;9:1068-1076.
14. Harmankaya O, Ozturk Y, Basturk T, Obek A. Urinary excretion of N-acetyl-beta-D-glucosaminidase in newly diagnosed essential hypertensive patients and its changes with effective antihypertensive therapy. Int Urol Nephrol 2001;32:583-584.
15. Ruilope LM. Microalbuminuria as risk in essential hypertension. Nephrol Dial Transplant 1997;12:2-5.
16. Minetti EE, Cozzi MG, Granata S, Guidi E. Accuracy of the urinary albumin titrator stick "Micral-Test" in kidney disease patients. Nephrol Dial Transplant 1997;12:78-80.
17. Pontremoli R, Sofia A, Ravera M, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study. Hypertension 1997;30:1135-1143.
18. Hiratsuka N, Shiba K, Nishida K, Lizima S, Kimura M, Kobayashi S. Analysis of urinary albumin, transferrin, N-acetyl-β-D-glucosaminidase and β2-microglobulin in patients with impaired glucose tolerance. J Clin Lab Anal 1998;12:351-355.
19. Bosomworth MP, Aparicio SR, Hay NM. Urine N-acetyl-beta-D-glucosaminidase - a marker of tubular damage? Nephrol Dial Transplant 1999;14:620-626.
20. Agirbasli M, Radhakrishnamurtly B, Jiang X, Bao W, Bereason GS. Urinary N-acetyl-beta-D-glucosaminidase changes in relation to age, sex, race, and diastolic and systolic blood pressure in a young adult biracial population. Am J Hypertens 1996;9:157-161.
21. Mueller PW, Hall WD, Caudill SP, MacNeil ML, Arepally A. An in-depth examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension. Am J Hypertens 1995;8:1072-1082.